Compounds > erlotinib
Page last updated: 2024-09-05

erlotinib and 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine

erlotinib has been researched along with 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine in 1 studies

Compound Research Comparison

Studies
(erlotinib)		Trials
(erlotinib)		Recent Studies (post-2010)
(erlotinib)		Studies
(2',3'-didehydro-3'-deoxy-4'-ethynylthymidine)		Trials
(2',3'-didehydro-3'-deoxy-4'-ethynylthymidine)		Recent Studies (post-2010) (2',3'-didehydro-3'-deoxy-4'-ethynylthymidine)
221018033317

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Talele, TT1

Other Studies

1 other study(ies) available for erlotinib and 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine

ArticleYear
Acetylene Group, Friend or Foe in Medicinal Chemistry.
    Journal of medicinal chemistry, 2020, 06-11, Volume: 63, Issue:11

    Topics: Acetylene; Alkynes; Animals; Anti-Inflammatory Agents; Chemistry, Pharmaceutical; Click Chemistry; Half-Life; HIV Reverse Transcriptase; HIV-1; Humans; Macrophages; Mice; Protein Kinase Inhibitors; Rats; Reverse Transcriptase Inhibitors

2020